Latest filing published 29 Dec 2021 for Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.).
Brian Peters appears in our data through filings on Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) shares, published by SEDI. We count 5 filings; the first trade dates from 16 October 2018 and the latest from 24 December 2021.
Purchases make up the whole of the open-market record (2 purchases, €537). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 option exercises. Since January 2021: 2 purchases and no sales on the market.
Most recently, on 29 December 2021, the filings show an option exercise in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). The last purchase on record was published on 7 December 2021, which is 1,785 days ago. Filings reach the SEDI feed a median of 5 days after the trade. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations